Institutional investors purchased a net $25.5 million shares of GILD during the quarter ended December 2017 and now own 81.65% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 10.5 Million shares of Gilead Sciences Inc
DEUTSCHE ASSET MANAGEMENT INVEST... Bought 7.6 Million shares of Gilead Sciences Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 7.0 Million shares of Gilead Sciences Inc